NIH-funded research NIH-funded research

How a pneumonia toxin damages the lung lining

Official title: Mechanism of Toxin Mediated Damage to the Lung Epithelium during S. pneumoniae Infection

Funded at San Jose State University · NIH-11330567 · Data updated 2026-11-12

This project looks at how a toxin made by Streptococcus pneumoniae damages the cells that line the lungs during pneumococcal infection to help people with pneumonia.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionSan Jose State University
NIH-funded
Lab location1 site (San Jose, United States)
Project startApril 1, 2024
Project endMarch 31, 2028
Funding year2026
Award (this year)$146,500
NIH project number5R16AI182337-03
Project IDNIH-11330567 on NIH RePORTER

Who could benefit from this research

Could help

People who have or are at risk for Streptococcus pneumoniae (pneumococcal) lung infections would be the most relevant group for future therapies informed by this work.

Less likely to help

People with lung problems caused by non-pneumococcal pathogens or non-infectious lung diseases are less likely to benefit directly from this specific toxin-focused work.

What this research studies

Researchers will grow human lung epithelial cells in a lab system that mimics the airway surface and expose them to pneumococcal bacteria that either do or do not produce the pneumolysin toxin. They will use ion-specific fluorescent dyes to watch how the toxin changes ion levels inside cells and test chemical tools that block those ion changes. The team will focus on how those ion shifts disrupt the cell–cell junctions that keep the lung barrier intact, studying both adherens and tight junctions. Results will clarify the steps by which the toxin weakens the lung lining and point to ways to protect it.

Why it matters

Potential benefit: If successful, this work could point to new ways to prevent or limit lung barrier damage during pneumococcal pneumonia, which may reduce lung injury and complications.

How similar studies have gone: Previous laboratory studies have shown that pneumolysin forms pores and disrupts host cells, but translating those basic findings into patient treatments is still in early stages.

Where this research is happening

  • San Jose State University
    San Jose, United States
    Active

Researchers

  • Principal investigator: Adams, Walter Isaiah — San Jose State University
  • Study coordinator: Adams, Walter Isaiah

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.